The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.

Participants will test whether a new care management fee and performance-based incentive payment for OUD treatment services reduces hospitalizations and improves health outcomes for Medicare fee-for-service patients with OUDs, including those dually eligible for Medicaid. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorizes $10 million annually in fiscal years 2021-2024 to pay for the treatment services. 

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
Health care experts and leaders from across the country presented sessions that offered conference attendees practical and adaptable solutions to issues such…
Headline
Michelle Hood, AHA executive vice president and COO, and Bill Gassen, president and CEO of Sanford Health in Sioux Falls, S.D., and chair-elect designate of…
Headline
Capitol Hill was the focus of the second morning of the AHA 2026 Rural Health Care Leadership Conference, taking place through tomorrow in…
Headline
The AHA Feb. 10 released its 2026 Rural Advocacy Agenda, laying out the association's key priorities for Congress, the administration, regulatory agencies and…
Headline
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law. The state law prohibits…